Loading...

Paul Phillips

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0835
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Taub PR, Ramirez-Sanchez I, Patel M, Higginbotham E, Moreno-Ulloa A, Román-Pintos LM, Phillips P, Perkins G, Ceballos G, Villarreal F. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial. Food Funct. 2016 Sep 14; 7(9):3686-93. PMID: 27491778; PMCID: PMC5025384 [Available on 09/14/17].
    2. Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med. 2011 Jun; 78(6):393-403. PMID: 21632911.
      View in: PubMed
    3. Linares LA, Golomb BA, Jaojoco JA, Sikand H, Phillips PS. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening. Curr Drug Saf. 2009 Sep; 4(3):181-7. PMID: 19534642.
      View in: PubMed
    4. Phillips PS. Balancing randomized trials with anecdote. Ann Intern Med. 2009 Jun 16; 150(12):885-6. PMID: 19528568.
      View in: PubMed
    5. Phillips PS, Ciaraldi TP, Kim DL, Verity MA, Wolfson T, Henry RR. Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids. Endocrine. 2009 Feb; 35(1):38-46. PMID: 19051066.
      View in: PubMed
    6. Phillips PS, Haas RH. Statin myopathy as a metabolic muscle disease. Expert Rev Cardiovasc Ther. 2008 Aug; 6(7):971-8. PMID: 18666847.
      View in: PubMed
    7. Vladutiu GD, Simmons Z, Isackson PJ, Tarnopolsky M, Peltier WL, Barboi AC, Sripathi N, Wortmann RL, Phillips PS. Genetic risk factors associated with lipid-lowering drug-induced myopathies. Muscle Nerve. 2006 Aug; 34(2):153-62. PMID: 16671104.
      View in: PubMed
    8. Phillips PS, Haas RH. Observations from a statin myopathy clinic. Arch Intern Med. 2006 Jun 12; 166(11):1232-3; author reply 1233. PMID: 16772252.
      View in: PubMed
    9. Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med. 2006 May; 119(5):400-9. PMID: 16651050.
      View in: PubMed
    10. Havranek JM, Wolfsen AR, Warnke GA, Phillips PS. Monotherapy with ezetimibe causing myopathy. Am J Med. 2006 Mar; 119(3):285-6. PMID: 16490482.
      View in: PubMed
    11. Sikand H, Jaojoco J, Linares L, Phillips PS. Atypical antipsychotic drugs, dementia, and risk of death. JAMA. 2006 Feb 01; 295(5):495; author reply 496-7. PMID: 16449610.
      View in: PubMed
    12. Phillips PS. How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Nat Clin Pract Cardiovasc Med. 2005 Mar; 2(3):130-1. PMID: 16265453.
      View in: PubMed
    13. Phillips PS. Ezetimibe and statin-associated myopathy. Ann Intern Med. 2004 Oct 19; 141(8):649. PMID: 15492351.
      View in: PubMed
    14. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002 Oct 01; 137(7):581-5. PMID: 12353945.
      View in: PubMed